WebMar 22, 2024 · CTGF Antibody (E-5) is an IgG 2a κ mouse monoclonal CTGF antibody (also designated CCN2 antibody or IGFBP-8 antibody) that detects the CTGF protein of mouse, rat and human origin by WB, IP, IF and ELISA. CTGF Antibody (E-5) is available as both the non-conjugated anti-CTGF antibody form, as well as multiple conjugated forms … WebJun 22, 2006 · FG-3019 is an investigational fully human monoclonal antibody against CTGF. In a phase 1 study of FG-3019 in patients with idiopathic pulmonary fibrosis, FG-3019 was found safe and well tolerated. Currently, FG-3019 is the subject of a phase 1b study in diabetic patients with incipient nephropathy.
CTGF Antibody Monoclonal IGFBP-8 Antibody ProSpec
WebApr 30, 2024 · As of December 31, 2024, there were a total of 250 integrated projects, including 121 projects in pre-clinical development stage, 112 projects in early-phase (phase I and II) clinical development ... WebJun 16, 2024 · Pamrevlumab, an anti-CTGF human monoclonal antibody, is in clinical development for the treatment of locally advanced unresectable pancreatic cancer (LAPC), Duchenne muscular dystrophy (DMD), and ... flashcard biology
CTGF regulates cell proliferation, migration, and glucose …
WebNot for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption. TARGET. ... (50 μg) were separated by 10% SDS-PAGE, and the membrane was blotted with CTGF antibody (GTX124232) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody (GTX213110-01) was used to detect the primary … WebInhibiting CTGF with antisense oligonucleotides, small interfering RNA, or neutralizing antibodies has been reported to reduce fibrosis in experimental models of kidney disease (Lee et al., 2015). The results of a phase I trial of FG-3019, an anti-CTGF antibody, demonstrated that this agent reduced albuminuria in patients with diabetic nephropathy. flash card blank